Ernexa Therapeutics Inc.

Nasdaq:ERNANasdaq:ERNAW

Pharmaceutical Preparations·CAMBRIDGE, MA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/7/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/7/25	→
10-K	FY 2024	12/31/24	3/12/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
↓

Earnings Releases (8-K)

3 shown

Filed	Period
3/20/23	Q1 FY2023	→
4/15/22	Q1 FY2022	→
8/17/21	Q3 FY2021	→

News (8-K)

77 shown

Filed	Type	Description
2/26/26	Reg FD	Regulation FD Disclosure	→
2/11/26	Agreement	Entry into a Material Definitive Agreement	→
12/11/25	Reg FD	Regulation FD Disclosure	→
7/7/25	Other	Changes in Registrant's Certifying Accountant	→
6/12/25	Other	Amendments to Articles of Incorporation or Bylaws	→
6/9/25	Other	Unregistered Sales of Equity Securities	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
2/10/26	424B5	424B5	→
2/5/26	S-1/A	S-1/A	→
2/4/26	S-1/A	S-1/A	→
2/3/26	S-1	S-1	→
6/18/25	424B3	424B3	→
6/11/25	S-8	S-8	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

8-K

Feb 26, 2026

0001493152-26-0081828-K

Feb 26, 2026

24.2 MB

SCHEDULE 13D/A

Feb 17, 2026

0001104659-26-016685

—

11.6 KB

Feb 17, 2026

0001104659-26-016680OWNERSHIP DOCUMENT

Feb 10, 2026

7.8 KB

8-K

Feb 11, 2026

0001493152-26-0062278-K

Feb 6, 2026

1.3 MB

424B5

Feb 10, 2026

0001493152-26-005898424B5

—

2.9 MB

EFFECT

Feb 5, 2026

9999999995-26-000458

—

2.0 KB

CERT

Feb 5, 2026

0001354457-26-000143

—

122.8 KB

8-A12B

Feb 5, 2026

0001493152-26-0052268-A12B

—

54.1 KB

S-1/A

Feb 5, 2026

0001493152-26-005215S-1/A

—

17.2 MB

S-1/A

Feb 4, 2026

0001493152-26-004987S-1/A

—

15.6 MB

S-1

Feb 3, 2026

0001493152-26-004809S-1

—

15.5 MB

SCHEDULE 13G/A

Dec 19, 2025

0001193125-25-326739

—

15.1 KB

SCHEDULE 13G/A

Dec 16, 2025

0001104659-25-121683

—

12.0 KB

8-K

Dec 11, 2025

0001493152-25-0271678-K

Dec 11, 2025

15.5 MB

10-Q

Nov 7, 2025

0001493152-25-02128710-Q

Sep 30, 2025

5.7 MB

DRS

Oct 23, 2025

0001493152-25-018969

—

585.6 KB

SCHEDULE 13G/A

Aug 18, 2025

0001104659-25-079777

—

7.8 KB

10-Q

Aug 13, 2025

0001493152-25-01191010-Q

Jun 30, 2025

5.3 MB

Jul 7, 2025

0001641172-25-018063

Jun 21, 2025

7.2 KB

8-K

Jul 7, 2025

0001641172-25-0180098-K

Jun 30, 2025

208.1 KB

EFFECT

Jun 18, 2025

9999999995-25-001964

—

2.0 KB

424B3

Jun 18, 2025

0001641172-25-015608424B3

—

115.0 KB

CORRESP

Jun 16, 2025

0001641172-25-015240

—

11.9 KB

UPLOAD

Jun 16, 2025

0000000000-25-006284

—

39.5 KB

8-K

Jun 12, 2025

0001641172-25-0148778-K

Jun 12, 2025

211.4 KB

25 filings shown

Filed	Form	Description
4/14/25	DEF 14A	DEF 14A	→
4/3/25	PRE 14A	PRE 14A	→
10/7/24	DEF 14A	DEF 14A	→
9/27/24	PRE 14A	PRE 14A	→
5/10/23	DEFA14A	DEFA14A	→
5/5/23	DEFA14A	DEFA14A	→
↓

Ernexa Therapeutics Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/17/26	4	OWNERSHIP DOCUMENT	→
7/7/25	4	4	→
6/11/25	4	OWNERSHIP DOCUMENT	→
5/7/25	4/A	OWNERSHIP DOCUMENT	→
4/4/25	4	OWNERSHIP DOCUMENT	→
2/10/25	4	4	→
↓